Deep brain stimulation: neuropsychological and neuropsychiatric issues
- PMID: 16810676
- DOI: 10.1002/mds.20963
Deep brain stimulation: neuropsychological and neuropsychiatric issues
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.
Similar articles
-
Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease.Brain Res Rev. 2010 Oct 5;65(1):1-13. doi: 10.1016/j.brainresrev.2010.04.010. Epub 2010 May 10. Brain Res Rev. 2010. Retraction in: Brain Res. 2011 Oct 24;1419:117. doi: 10.1016/j.brainres.2011.09.001. PMID: 20457181 Retracted. Review.
-
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.Brain. 2011 Jul;134(Pt 7):2074-84. doi: 10.1093/brain/awr121. Epub 2011 Jun 11. Brain. 2011. PMID: 21666262 Clinical Trial.
-
The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.J Neurol Sci. 2008 Oct 15;273(1-2):19-24. doi: 10.1016/j.jns.2008.06.010. Epub 2008 Jul 21. J Neurol Sci. 2008. PMID: 18640690 Clinical Trial.
-
Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.Mov Disord. 2009 Aug 15;24(11):1621-8. doi: 10.1002/mds.22603. Mov Disord. 2009. PMID: 19514093 Clinical Trial.
-
[Nonmotor symptoms in Parkinson's disease and deep brain stimulation].Rev Neurol. 2010 Feb 8;50 Suppl 2:S95-104. Rev Neurol. 2010. PMID: 20205149 Review. Spanish.
Cited by
-
Did My Brain Implant Make Me Do It? Questions Raised by DBS Regarding Psychological Continuity, Responsibility for Action and Mental Competence.Neuroethics. 2013;6(3):527-539. doi: 10.1007/s12152-010-9093-1. Epub 2010 Sep 16. Neuroethics. 2013. PMID: 24273622 Free PMC article.
-
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.Brain Behav. 2018 Jul;8(7):e01008. doi: 10.1002/brb3.1008. Epub 2018 Jun 1. Brain Behav. 2018. PMID: 29856137 Free PMC article.
-
Safety and feasibility of nucleus accumbens stimulation in five patients with epilepsy.J Neurol. 2014 Aug;261(8):1477-84. doi: 10.1007/s00415-014-7364-1. Epub 2014 May 7. J Neurol. 2014. PMID: 24801491 Free PMC article.
-
Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat.J Gene Med. 2010 Apr;12(4):385-98. doi: 10.1002/jgm.1449. J Gene Med. 2010. PMID: 20352617 Free PMC article.
-
Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report.J ECT. 2014 Sep;30(3):e13-5. doi: 10.1097/YCT.0b013e31829e0afa. J ECT. 2014. PMID: 23859977 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials